Hormone therapy can be an effective treatment against some breast cancers that are affected by hormones, like oestrogen and ...

Patients whose cancers are very weakly estrogen receptor positive likely still benefit from adjuvant endocrine therapy, according to a study presented at ASCO.

The WHO's 194 member states have been negotiating for two years on an agreement that could increase collaboration before and ...

(UroToday.com) The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 31 st and ...

A lower risk of disease recurrence was seen when combining anthracycline and chemotherapy to treat certain patients with ...

Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...

Another emerging paradigm is the treatment of advanced clear cell RCC patients with disease progression following adjuvant ...

The stock’s market cap achieved a total value of $59.36 million as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to ...

Iovance's autologous TIL therapy plus Merck's PD-1 drug led to encouraging responses in a Phase II trial, but some ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

accessible to intratumoral injection. For both arms, adjuvant treatment with approved drugs was allowed. Nidlegy was injected intralesionally up to four times, once a week before surgery. The trial ...